MedTrace Logo

Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders

NCT00004767 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2005-06-24

No results posted yet for this study

Summary

OBJECTIVES:

I. Assess the safety and efficacy of sodium phenylbutyrate, sodium benzoate, sodium phenylacetate, and dietary intervention in patients with urea cycle disorders.

Conditions

  • Amino Acid Metabolism, Inborn Errors

Interventions

DRUG

Sodium Benzoate

DRUG

Sodium Phenylacetate

DRUG

Sodium Phenylbutyrate

BEHAVIORAL

Dietary Intervention

Sponsors & Collaborators

Principal Investigators

  • Saul W. Brusilow · Johns Hopkins University

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1985-01-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004767 on ClinicalTrials.gov